Cite

HARVARD Citation

    Frank, M. et al. (n.d.). PHASE I/II CLINICAL TRIAL OF AN ACTIVATED WHOLE TUMOR CELL VACCINE FOLLOWED BY TRANSFER OF IMMUNE T CELLS IN PATIENTS WITH MANTLE CELL LYMPHOMA. Hematological oncology. pp. 207-208. [Online]. 
  
Back to record